Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 59

Sort by

Sort Order Select

Journal Articles

F5-Atlanta induced Exitron Splicing

Karen L Zimowski, Maya Maarouf, Julie R Wechsler, Carlos Lozano, Seema R Patel, Shannon L Meeks, Christopher B. Doering

Blood (2024) 144 (Supplement 1): 429.

https://doi.org/10.1182/blood-2024-208391

Published: 2024

Journal Articles

Hemophilia A Research Program (HARP): A Novel Study Design for a Multicenter and Decentralized Prospective Observational Longitudinal Cohort Study in Hemophilia A

Jill M Johnsen, Shannon L Meeks, Grier P Page, Bhavya S Doshi, Marian T Sullivan, Mary-Anne Ardini, Angela C Weyand, Lynn Malec

Blood (2023) 142 (Supplement 1): 5494.

https://doi.org/10.1182/blood-2023-191010

Published: 2023

Journal Articles

Eptacog Beta (rFVIIa) Has a Low Incidence of Spontaneous Rebleeding through 24 and 48 Hours in Adult and Adolescent Patients with Hemophilia A or B with Inhibitors

Amy L. Dunn, Yesim Dargaud, Yasmina L. Abajas, Manuel Carcao, Giancarlo Castaman, Adam Giermasz, Cédric Hermans, Magdalena D. Lewandowska, Johnny Mahlangu, Shannon L. Meeks, Wolfgang A. Miesbach, Michael Recht, Vanessa Salinas, Tammuella Chrisentery-Singleton, Hongying Wang, Ian S Mitchell, Guy Young

Blood (2022) 140 (Supplement 1): 8485–8488.

https://doi.org/10.1182/blood-2022-157343

Published: 2022

Journal Articles

Quantitative Platelet Adhesion and Platelet Geometry-Sensing Assays for Evaluating Mild Bleeding Disorders

Sally Azer, Oluwamayokun Oshinowo, Meredith E. Fay, Yumiko Sakurai, Megan C. Brown, Carolyn Bennett, Shannon L. Meeks, Wilbur A. Lam

Blood (2022) 140 (Supplement 1): 5538–5539.

https://doi.org/10.1182/blood-2022-162598

Published: 2022

Journal Articles

Marginal Zone B Cells Facilitate CD4 T Cell Proliferation in Response to Factor VIII in Mice with Hemophilia Α

Patricia E Zerra, James W. McCoy, Seema R Patel, Ernest T. Parker, Wallace H. Baldwin, John Healey, Shannon L. Meeks, Sean R. Stowell

Blood (2022) 140 (Supplement 1): 2703–2704.

https://doi.org/10.1182/blood-2022-167501

Published: 2022

Journal Articles

Epitope Dependent Augmentation of the Immune Response in Hemophilia Α Mice Immunized with Factor VIII/Antibody Immune Complexes

Glaivy Batsuli, MD, Seema R Patel, PhD, Courtney Cox, MSc, Wallace H. Baldwin, John S. Lollar, MD, Shannon L. Meeks, MD

Blood (2019) 134 (Supplement_1): 2387.

https://doi.org/10.1182/blood-2019-127436

Published: 2019

Journal Articles

The Immune Response to Murine Factor VIII in Single Exon Deletion and Total Gene Deletion Murine Models of Hemophilia a

Seema R Patel, PhD, Wallace H. Baldwin, Courtney Cox, MSc, John Healey, BS, Ernest T. Parker, Glaivy Batsuli, MD, Shannon L. Meeks, MD

Blood (2019) 134 (Supplement_1): 1109.

https://doi.org/10.1182/blood-2019-130890

Published: 2019

Journal Articles

Severe Bleeding Events in Hemophilia Α Patients Receiving Emicizumab Prophylaxis

Karen L. Zimowski, MD, Glaivy M. Batsuli, MD, Paulette Bryant, MD, Jenny McDaniel, MD, Kelly Tickle, MSN, APN, PPCNP-BC, Shannon L. Meeks, MD, Robert F. Sidonio, Jr., MD MSc

Blood (2019) 134 (Supplement_1): 1126.

https://doi.org/10.1182/blood-2019-126659

Published: 2019

Journal Articles

Data Coming out of the Human Inhibitor PUP Study (HIPS) Reveal 4 Subgroups of Patients with Distinct Antibody Signatures

Blood (2018) 132 (Supplement 1): 3774.

https://doi.org/10.1182/blood-2018-99-115979

Published: 2018

Journal Articles

The Atlanta Protocol: Immune Tolerance Induction in Pediatric Patients with Hemophilia a and Inhibitors on Emicizumab

Glaivy M. Batsuli, MD, Karen L. Zimowski, MD, Kelly Tickle, MSN, APN, PPCNP-BC, Shannon L. Meeks, MD, Robert F. Sidonio, Jr., MD

Blood (2018) 132 (Supplement 1): 634.

https://doi.org/10.1182/blood-2018-99-114249

Published: 2018

Journal Articles

Maintaining Perioperative Hemostasis in Patients with Severe Hemophilia A and Inhibitors Receiving Emicizumab Prophylaxis

Karen L. Zimowski, MD, Glaivy M. Batsuli, MD, Mark T. Reding, MD, Jatin Rana, MD, Michael U. Callaghan, MD, Kelly Tickle, MSN, APN, PPCNP-BC, Shannon L. Meeks, MD, Robert F. Sidonio, Jr., MD

Blood (2018) 132 (Supplement 1): 635.

https://doi.org/10.1182/blood-2018-99-115089

Published: 2018

Journal Articles

Marginal zone B cells are critical to factor VIII inhibitor formation in mice with hemophilia A

Patricia E. Zerra, Courtney Cox, W. Hunter Baldwin, Seema R. Patel, Connie M. Arthur, Pete Lollar, Shannon L. Meeks, Sean R. Stowell

Blood (2017) 130 (23): 2559–2568.

https://doi.org/10.1182/blood-2017-05-782912

Published: 2017

Includes: Supplemental data

Journal Articles

Epitope Mapping of Inhibitor Patient Plasmas during Immune Tolerance Induction

Shannon L. Meeks, MD, Courtney Cox, MSc, W. Hunter Baldwin, BS

Blood (2017) 130 (Supplement 1): 2364.

https://doi.org/10.1182/blood.V130.Suppl_1.2364.2364

Published: 2017

Journal Articles

The Impact of Anti-Factor VIII A1 and A3 Domain Antibodies in the Immune Reponse to Factor VIII in Patients with Hemophilia a

Jasmine C Ito, Courtney Cox, MSc, W. Hunter Baldwin, BS, Christopher B Doering, PhD, Shannon L. Meeks, MD

Blood (2017) 130 (Supplement 1): 2373.

https://doi.org/10.1182/blood.V130.Suppl_1.2373.2373

Published: 2017

Journal Articles

Longitudinal Antibody Signatures Following FVIII Replacement Therapy in Previously Untreated Patients with Severe Hemophilia Α- New Insights from the Hemophilia Inhibitor PUP Study (HIPS)

Bagirath Gangadharan, PhD, Birgit Reipert, Fritz Scheiflinger, PhD, Joel Bowen, Elizabeth Donnachie, PhD, Karin Fijn van Draat, Ralph A. Gruppo, MD, Jenny Klintman, MD PhD, Christoph Male, MD, Catherine E. McGuinn, MD, Shannon L. Meeks, MD, Michael Recht, MD PhD, Margaret V. Ragni, MD MPH, Hassan M. Yaish, MD, Amy D. Shapiro, MD, Donald L Yee, MD, Vlad Calin Radulescu, MD, Elena Santagostino, Deborah Brown, MD

Blood (2017) 130 (Supplement 1): 88.

https://doi.org/10.1182/blood.V130.Suppl_1.88.88

Published: 2017

Journal Articles

Platelet-Based Factor VIII Activity Is Inhibited By Anti-C2 Domain Antibodies That Donâ€™t Significantly Inhibit Factor VIII Activity in a Standard Assay

Madhumouli Chatterjee, PhD, Shannon L. Meeks, MD, Valerie Anne Novakovic, MS, John S. Lollar, MD, Gary E Gilbert, MD

Blood (2017) 130 (Supplement 1): 2345.

https://doi.org/10.1182/blood.V130.Suppl_1.2345.2345

Published: 2017

Journal Articles

Thrombin Generation in Patients with Severe Hemophilia A May Be Variable but Predictive of Response to Treatment

Ruchika Sharma, MD, Amy L. Dunn, MD, Shawn M. Jobe, MD PhD, Traci Leong, PhD, Shannon L. Meeks, MD

Blood (2017) 130 (Supplement 1): 3687.

https://doi.org/10.1182/blood.V130.Suppl_1.3687.3687

Published: 2017

Journal Articles

Ethical Decision Making Framework in Previously Untreated Severe Hemophilia A Patients

Ashley Foster Lanzel, MD, J. Michael Soucie, PhD, Shannon L. Meeks, MD, Robert F. Sidonio, Leonard Ortmann, PhD, Drue H Barrett, PhD

Blood (2017) 130 (Supplement 1): 5583.

https://doi.org/10.1182/blood.V130.Suppl_1.5583.5583

Published: 2017

Journal Articles

The Impact of Specific Factor VIII Domains on Uptake By Dendritic Cells

Glaivy M. Batsuli, MD, Shannon L. Meeks, MD, John S. Lollar, MD

Blood (2017) 130 (Supplement 1): 1066.

https://doi.org/10.1182/blood.V130.Suppl_1.1066.1066

Published: 2017

Journal Articles

Very High Dose Factor VIII Needed to Prevent Bleeding in the Presence of a Low Titer Anti-C1 Domain Antibody

Jasmine Ito, Rylee Mercer, Wallace Hunter Baldwin, BS, Glaivy Batsuli, MD, Shannon L. Meeks, MD

Blood (2016) 128 (22): 3772.

https://doi.org/10.1182/blood.V128.22.3772.3772

Published: 2016

NARROW

F5-Atlanta induced Exitron Splicing

Hemophilia A Research Program (HARP): A Novel Study Design for a Multicenter and Decentralized Prospective Observational Longitudinal Cohort Study in Hemophilia A

Eptacog Beta (rFVIIa) Has a Low Incidence of Spontaneous Rebleeding through 24 and 48 Hours in Adult and Adolescent Patients with Hemophilia A or B with Inhibitors

Quantitative Platelet Adhesion and Platelet Geometry-Sensing Assays for Evaluating Mild Bleeding Disorders

Marginal Zone B Cells Facilitate CD4 T Cell Proliferation in Response to Factor VIII in Mice with Hemophilia Α

Epitope Dependent Augmentation of the Immune Response in Hemophilia Α Mice Immunized with Factor VIII/Antibody Immune Complexes

The Immune Response to Murine Factor VIII in Single Exon Deletion and Total Gene Deletion Murine Models of Hemophilia a

Severe Bleeding Events in Hemophilia Α Patients Receiving Emicizumab Prophylaxis

Data Coming out of the Human Inhibitor PUP Study (HIPS) Reveal 4 Subgroups of Patients with Distinct Antibody Signatures

The Atlanta Protocol: Immune Tolerance Induction in Pediatric Patients with Hemophilia a and Inhibitors on Emicizumab

Maintaining Perioperative Hemostasis in Patients with Severe Hemophilia A and Inhibitors Receiving Emicizumab Prophylaxis

Marginal zone B cells are critical to factor VIII inhibitor formation in mice with hemophilia A

Epitope Mapping of Inhibitor Patient Plasmas during Immune Tolerance Induction

The Impact of Anti-Factor VIII A1 and A3 Domain Antibodies in the Immune Reponse to Factor VIII in Patients with Hemophilia a

Longitudinal Antibody Signatures Following FVIII Replacement Therapy in Previously Untreated Patients with Severe Hemophilia Α- New Insights from the Hemophilia Inhibitor PUP Study (HIPS)

Platelet-Based Factor VIII Activity Is Inhibited By Anti-C2 Domain Antibodies That Donâ€™t Significantly Inhibit Factor VIII Activity in a Standard Assay

Thrombin Generation in Patients with Severe Hemophilia A May Be Variable but Predictive of Response to Treatment

Ethical Decision Making Framework in Previously Untreated Severe Hemophilia A Patients

The Impact of Specific Factor VIII Domains on Uptake By Dendritic Cells

Very High Dose Factor VIII Needed to Prevent Bleeding in the Presence of a Low Titer Anti-C1 Domain Antibody

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only